PlexusDx patients often ask whether their semaglutide or tirzepatide treatment affects their ability to contribute to blood banks and plasma centers
[Glutathione-S-transferase and glutathione in the liver and blood of rats poisoned by [PMID: 7448078] Laboratory literature summary: [Glutathione-S-transferase and glutathione in the liver and blood of rats poisoned by thioacetamide]
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context by revealing genetic predispositions in GLP-1 receptor pathways, thyroid-related metabolic genes (like FTO and MC4R variants), and metabolic responsiveness factors
:
[7]: Quetiapine (300-600 mg day): Seven out of seven studies positive, N = 2,152, SDM: 0.35 (0.23-0.47), Olanzapine: four RCTs, N = 732 (SDM: 0.35 (0.17-0.54), Lurasidone: Four RCTs, N = 1,029, SDM: 0.29 (0.14-0.45) and Cariprazine: Four RCTs, N = 997, SDM: 0.23 (0.06-0.39)
So thats two weeks of doxy followed by four weeks of a cell-wall drug